Literature DB >> 21820307

Amyloidosis and exercise intolerance in ANO5 muscular dystrophy.

Margherita Milone1, Teerin Liewluck, Thomas L Winder, Paolo T Pianosi.   

Abstract

Anoctamin 5 and dysferlin mutations can result in myopathies with similar clinical phenotype. Amyloid deposits can occur in the muscle of patients with dysferlinopathy. We describe a 53-year-old woman with exercise intolerance since childhood, recurrent rhabdomyolysis and late-onset weakness. Muscle biopsy showed amyloid deposits within the blood vessel walls and around muscle fibers. Mutation analysis identified two pathogenic heterozygous mutations in anoctamin 5 and no mutations in dysferlin. To our knowledge this is the first report of muscle amyloidosis in anoctamin 5 muscular dystrophy. This finding suggests that patients with amyloid in muscle should be screened for anoctamin 5 muscular dystrophy.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820307     DOI: 10.1016/j.nmd.2011.07.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  15 in total

1.  Myopathy caused by anoctamin 5 mutations and necrotizing vasculitis.

Authors:  Isabelle Pénisson-Besnier; Jean-Paul Saint-André; Debbie Hicks; Anna Sarkozy; Anne Croué; Judith Hudson; Hanns Lochmüller; Frédéric Dubas
Journal:  J Neurol       Date:  2012-04-19       Impact factor: 4.849

2.  Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.

Authors:  Danielle A Griffin; Ryan W Johnson; Jarred M Whitlock; Eric R Pozsgai; Kristin N Heller; William E Grose; W David Arnold; Zarife Sahenk; H Criss Hartzell; Louise R Rodino-Klapac
Journal:  Hum Mol Genet       Date:  2016-02-23       Impact factor: 6.150

3.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

4.  Exercise Intolerance in Facioscapulohumeral Muscular Dystrophy.

Authors:  Kathryn A Vera; Mary McConville; Aline Glazos; William Stokes; Michael Kyba; Manda Keller-Ross
Journal:  Med Sci Sports Exerc       Date:  2022-02-21

5.  A novel missense mutation in ANO5/TMEM16E is causative for gnathodiaphyseal dyplasia in a large Italian pedigree.

Authors:  Caterina Marconi; Paolo Brunamonti Binello; Giovanni Badiali; Emanuela Caci; Roberto Cusano; Joseph Garibaldi; Tommaso Pippucci; Alberto Merlini; Claudio Marchetti; Kerry J Rhoden; Luis J V Galietta; Faustina Lalatta; Paolo Balbi; Marco Seri
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

Review 6.  Modulating Ca²⁺ signals: a common theme for TMEM16, Ist2, and TMC.

Authors:  Karl Kunzelmann; Ines Cabrita; Podchanart Wanitchakool; Jiraporn Ousingsawat; Lalida Sirianant; Roberta Benedetto; Rainer Schreiber
Journal:  Pflugers Arch       Date:  2015-12-23       Impact factor: 3.657

Review 7.  Rhabdomyolysis: a genetic perspective.

Authors:  Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan
Journal:  Orphanet J Rare Dis       Date:  2015-05-02       Impact factor: 4.123

8.  Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations.

Authors:  Marco Savarese; Giuseppina Di Fruscio; Giorgio Tasca; Lucia Ruggiero; Sandra Janssens; Jan De Bleecker; Marc Delpech; Olimpia Musumeci; Antonio Toscano; Corrado Angelini; Sabrina Sacconi; Lucio Santoro; Enzo Ricci; Kathleen Claes; Luisa Politano; Vincenzo Nigro
Journal:  Neuromuscul Disord       Date:  2015-03-30       Impact factor: 4.296

9.  Clinical and genetic features of anoctaminopathy in Saudi Arabia.

Authors:  Saeed Bohlega; Dorothy M Monies; Ahmad A Abulaban; Hatem N Murad; Hindi N Alhindi; Brian F Meyer
Journal:  Neurosciences (Riyadh)       Date:  2015-04       Impact factor: 0.906

10.  First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.

Authors:  Bolin Hu; Li Xiong; Yibiao Zhou; Xiaoqing Lu; Qianqian Xiong; Qing Liu; Xueliang Qi; Weijiang Ding
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.